Krystal Biotech, Inc.

Historical 13F Holders

Symbol
KRYS
CUSIP
501147102
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 501147102 since 12/18/2024, largest first.

Filer % of Class Filed
Krish S. Krishnan 13G/A
11.5% 5/4/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 5.1% 4/29/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
State Street Corp 13G 4.4% 2/5/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 26 83.3 k $27.7 M
2026 Q2 450 39.1 M $11.1 B
2026 Q1 385 28.4 M $7.32 B
2025 Q4 351 28.5 M $7.01 B
2025 Q3 307 28.3 M $4.99 B
2025 Q2 297 27.7 M $3.80 B
2025 Q1 322 27.7 M $4.99 B
2024 Q4 291 27.8 M $4.35 B
2024 Q3 310 28.4 M $5.15 B
2024 Q2 266 29.4 M $5.40 B
2024 Q1 263 26.3 M $4.68 B
2023 Q4 213 25.8 M $3.20 B
2023 Q3 208 24.5 M $2.84 B
2023 Q2 202 23.9 M $2.80 B
2023 Q1 178 21.9 M $1.76 B
2022 Q4 169 23.3 M $1.84 B
2022 Q3 162 20.9 M $1.46 B
2022 Q2 145 20.8 M $1.36 B
2022 Q1 146 20.6 M $1.37 B
2021 Q4 161 19.3 M $1.35 B
2021 Q3 133 16.3 M $851 M
2021 Q2 126 16.4 M $1.12 B
2021 Q1 123 16.5 M $1.27 B
2020 Q4 118 14.0 M $842 M
2020 Q3 106 14.4 M $623 M
2020 Q2 117 14.3 M $593 M
2020 Q1 93 11.6 M $502 M
2019 Q4 93 11.6 M $643 M
2019 Q3 89 11.5 M $400 M
2019 Q2 78 9.83 M $398 M
2019 Q1 58 6.71 M $223 M
2018 Q4 47 6.27 M $130 M
2018 Q3 25 2.74 M $48.0 M
2018 Q2 17 2.39 M $35.5 M
2018 Q1 12 3.08 M $31.0 M
2017 Q4 13 3.24 M $34.0 M
2017 Q3 13 3.14 M $31.3 M